Superagonism at G protein‐coupled receptors and beyond

No abstract is available for this paper.

• Publication year

  2016

• Venue

  British Journal of Pharmacology

• Publication date

  2016-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/bph.13278PMID 26276510PMCID PMC5338155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Superagonism at G protein‐coupled receptors and beyond

  2016cited by this paper
• Rational design of partial agonists for the muscarinic m1 acetylcholine receptor.

  2015cited by this paper
• Seven-transmembrane receptors

  2015cited by this paper
• Thematic Minireview Series: Cell Biology of G Protein Signaling

  2015cited by this paper
• Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity.

  2014cited by this paper
• Biased Agonism at G Protein‐Coupled Receptors: The Promise and the Challenges—A Medicinal Chemistry Perspective

  2014cited by this paper
• New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo.

  2014cited by this paper
• Muscarinic acetylcholine receptors: novel opportunities for drug development

  2014cited by this paper
• Dynamic ligand binding dictates partial agonism at a G protein-coupled receptor.

  2014cited by this paper
• New concepts in pharmacological efficacy at 7TM receptors: IUPHAR Review 2

  2013influential reference
• Agonists with supraphysiological efficacy at the muscarinic M2 ACh receptor

  2013cited by this paper
• Supra‐physiological efficacy at GPCRs: superstition or super agonists?

  2013cited by this paper
• The Concise Guide to Pharmacology 2013/14: Ligand-Gated Ion Channels

  2013cited by this paper
• The Concise Guide to Pharmacology 2013/14: G Protein-Coupled Receptors

  2013cited by this paper
• A single channel mutation alters agonist efficacy at 5-HT3A and 5-HT3AB receptors

  2013influential reference
• The Concise Guide to Pharmacology 2013/14: Enzymes

  2013cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

  2013cited by this paper
• Are GPCRs Still a Source of New Targets?

  2013cited by this paper
• The dynamic process of β(2)-adrenergic receptor activation.

  2013cited by this paper
• Quantifying biased agonism: understanding the links between affinity and efficacy

  2013cited by this paper
• Activation and allosteric modulation of a muscarinic acetylcholine receptor

  2013cited by this paper
• Signalling bias in new drug discovery: detection, quantification and therapeutic impact

  2012influential reference
• A simple method for quantifying functional selectivity and agonist bias.

  2012cited by this paper
• Taltirelin is a superagonist at the human thyrotropin-releasing hormone receptor

  2012influential reference
• The allosteric vestibule of a seven transmembrane helical receptor controls G-protein coupling

  2012cited by this paper
• Quantifying Ligand Bias at Seven-Transmembrane Receptors

  2011cited by this paper
• When simple agonism is not enough: emerging modalities of GPCR ligands.

  2011influential reference
• Crystal Structure of the β2Adrenergic Receptor-Gs protein complex

  2011cited by this paper
• Structure and Function of an Irreversible Agonist-β2 Adrenoceptor complex

  2010cited by this paper
• Structure of a nanobody-stabilized active state of the β2 adrenoceptor

  2010cited by this paper
• Conditional Superagonist CTL Ligands for the Promotion of Tumor-Specific CTL Responses

  2010cited by this paper
• Energy landscapes as a tool to integrate GPCR structure, dynamics, and function.

  2010cited by this paper
• The year in G protein-coupled receptor research.

  2010cited by this paper
• Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity

  2009cited by this paper
• Growth Hormone Secretagogues and Growth Hormone Releasing Peptides Act As Orthosteric Super-Agonists but Not Allosteric Regulators for Activation of the G Protein Gαo1 by the Ghrelin Receptor

  2009cited by this paper
• The structure and function of G-protein-coupled receptors

  2009cited by this paper
• Structural diversity of G protein-coupled receptors and significance for drug discovery

  2008cited by this paper
• Structure-based design of a superagonist ligand for the vitamin D nuclear receptor.

  2008cited by this paper
• Agonist binding, agonist affinity and agonist efficacy at G protein‐coupled receptors

  2008cited by this paper
• Structural diversity of G protein-coupled receptors and significance for drug discovery

  2008cited by this paper
• Dendrimer-epidermal growth factor conjugate displays superagonist activity.

  2008cited by this paper
• Heterotrimeric G protein activation by G-protein-coupled receptors

  2008cited by this paper
• Receptor-Drug Interaction: Europium Employment for Studying the Biochemical Pathway of G-Protein-Coupled Receptor Activation

  2008cited by this paper
• Activation of G protein-coupled receptors.

  2007cited by this paper
• Conformational complexity of G-protein-coupled receptors.

  2007cited by this paper
• Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse.

  2006cited by this paper
• Neonicotinoid insecticides display partial and super agonist actions on native insect nicotinic acetylcholine receptors

  2006cited by this paper
• How many drug targets are there?

  2006cited by this paper
• Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors.

  2006cited by this paper
• Heterotrimeric G‐proteins: a short history

  2006cited by this paper
• Identification of new gonadotrophin-releasing hormone partial agonists.

  2006cited by this paper
• Low Affinity Analogs of Thyrotropin-releasing Hormone Are Super-agonists*

  2006cited by this paper
• Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}.

  2006cited by this paper
• International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List

  2005cited by this paper
• Superagonism at the Human Somatostatin Receptor Subtype 4

  2005influential reference
• An investigation of whether agonist‐selective receptor conformations occur with respect to M2 and M4 muscarinic acetylcholine receptor signalling via Gi/o and Gs proteins

  2005influential reference
• Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases

  2005cited by this paper
• Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling.

  2005influential reference
• GnRH analogues--agonists and antagonists.

  2005cited by this paper
• Super Agonist Actions of Clothianidin and Related Compounds on the SADβ2 Nicotinic Acetylcholine Receptor Expressed in Xenopus laevis Oocytes

  2004cited by this paper
• The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

  2003cited by this paper
• International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology

  2003cited by this paper
• Principles: extending the utility of [35S]GTP gamma S binding assays.

  2003cited by this paper
• Efficacy at g-protein-coupled receptors

  2002cited by this paper
• Discovery of non-zwitterionic GABA(A) receptor full agonists and a superagonist.

  2002influential reference
• Heterozygous α2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists

  2002cited by this paper
• Signalling: Seven-transmembrane receptors

  2002cited by this paper
• Dual effects of muscarinic M2 acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists

  2001cited by this paper
• Classical and new roles of β-arrestins in the regulation of G-PROTEIN-COUPLED receptors

  2001cited by this paper
• Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTL1

  2000cited by this paper
• A fusion protein of interleukin‐11 and soluble interleukin‐11 receptor acts as a superagonist on cells expressing gp130

  1999cited by this paper
• Synthesis and functional characterization of novel derivatives related to oxotremorine and oxotremorine-M.

  1999cited by this paper
• Qualitative and quantitative assessment of relative agonist efficacy.

  1999cited by this paper
• Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.

  1998cited by this paper
• A bioactive designer cytokine for human hematopoietic progenitor cell expansion

  1997cited by this paper
• Structural basis of receptor/G protein coupling selectivity studied with muscarinic receptors as model systems.

  1997cited by this paper
• CD28‐mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: Evidence for functionally distinct forms of CD28

  1997cited by this paper
• A MODIFICATION OF RECEPTOR THEORY

  1997influential reference
• Analogues of CTL epitopes with improved MHC class‐I binding capacity elicit anti‐melanoma CTL recognizing the wild‐type epitope

  1997cited by this paper
• CD28/B7 system of T cell costimulation.

  1996cited by this paper
• The Interaction of an Epidermal Growth Factor/Transforming Growth Factor α Tail Chimera with the Human Epidermal Growth Factor Receptor Reveals Unexpected Complexities*

  1996cited by this paper
• Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity.

  1995cited by this paper
• Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.

  1995cited by this paper
• International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification.

  1994influential reference
• A novel mechanism for coupling of m4 muscarinic acetylcholine receptors to calmodulin-sensitive adenylyl cyclases: crossover from G protein-coupled inhibition to stimulation.

  1994cited by this paper
• GCRDb: a G-protein-coupled receptor database.

  1994cited by this paper
• GCRDB: A G-PROTEIN-COUPLED RECEPTOR DATABASE

  1994cited by this paper
• Muscarinic receptors--characterization, coupling and function.

  1993cited by this paper
• The immune system in health and disease.

  1992cited by this paper
• Structure and Function of G Protein Coupled Receptors

  1990cited by this paper
• Hill coefficients and the logistic equation.

  1989cited by this paper
• The quantification of relative efficacy of agonists.

  1985cited by this paper
• The relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium.

  1985cited by this paper
• Operational models of pharmacological agonism

  1983cited by this paper
• Binding affinity and biological activity of gonadotropin releasing hormone agonists in isolated pituitary cells.

  1982cited by this paper
• COMPARISON OF DISSOCIATION CONSTANTS AND OF RELATIVE EFFICACIES OF SELECTED AGONISTS ACTING ON PARASYMPATHETIC RECEPTORS *

  1967cited by this paper
• Receptor reserve and threshold phenomena. I. Theory and experiments with autonomic drugs tested on isolated organs.

  1960cited by this paper
• Receptor reserve and threshold phenomena. I. Theory and experiments with autonomic drugs tested on isolated organs.

  1960cited by this paper
• Receptor Occupancy and Tissue Response

  1956cited by this paper

• Assessment of high-efficacy agonism in synthetic cannabinoid receptor agonists containing l-tert-leucinate.

  2026cites this paper
• Diazepine Agonists of the 5‑HT2C Receptor with Unprecedented Selectivity: Discovery of Bexicaserin (LP352)

  2025cites this paper
• Biased agonism in psychopharmacology: an opportunity to improve efficacy and safety of treatments

  2025cites this paper
• Structural and Dynamic Insights into the Activation of the μ-opioid Receptor by an Allosteric Modulator

  2025cites this paper
• A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets for breast cancer

  2024cites this paper
• GPCRVS - AI-driven Decision Support System for GPCR Virtual Screening

  2024cites this paper
• Assessment of high-efficacy agonism in synthetic cannabinoid receptor agonists containing l-tert-leucinate

  2024cites this paper
• Structural and dynamic insights into the activation of the μ-opioid receptor by an allosteric modulator

  2024cites this paper
• A subtle structural modification of a synthetic cannabinoid receptor agonist drastically increases its efficacy at the CB1 receptor

  2023cites this paper
• Mu-opioid receptor selective superagonists produce prolonged respiratory depression

  2023cites this paper
• Carfentanil is a β‐arrestin‐biased agonist at the μ opioid receptor

  2023cites this paper
• Activation mechanism of the μ-opioid receptor by an allosteric modulator

  2022cites this paper
• PTH1R Actions on Bone Using the cAMP/Protein Kinase A Pathway

  2022cites this paper
• Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state

  2021cites this paper
• Nanoporous gold: A review and potentials in biotechnological and biomedical applications

  2021cites this paper
• Single molecule analysis reveals positive allosteric modulators are required to stabilize the active state of a metabotropic glutamate receptor

  2021cites this paper
• Exploring Biased Agonism at FPR1 as a Means to Encode Danger Sensing †

  2020cites this paper
• Towards a method for the simultaneous quantification of Gαq activation β-arrestin2 recruitment

  2020cites this paper
• A Dynamic, Split-Luciferase-Based Mini-G Protein Sensor to Functionally Characterize Ligands at All Four Histamine Receptor Subtypes

  2020cites this paper
• Pharmacology and Therapeutics of Bronchodilators Revisited

  2019cites this paper
• Split luciferase-based assay for simultaneous analyses of the ligand concentration- and time-dependent recruitment of β-arrestin2.

  2019cites this paper
• Modelling and mathematical analysis of the M$_{2}$ receptor-dependent joint signalling and secondary messenger network in CHO cells.

  2018cites this paper
• Small‐Molecule Neuromedin U Receptor 2 Agonists Suppress Food Intake and Decrease Visceral Fat in Animal Models

  2018cites this paper
• A split luciferase-based probe for quantitative proximal determination of Gαq signalling in live cells

  2018cites this paper
• Discovery of a GPR40 Superagonist: The Impact of Aryl Propionic Acid α-Fluorination.

  2018cites this paper
• Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice.

  2018cites this paper
• Binding Kinetics and Pathways of Ligands to GPCRs.

  2017cites this paper
• Ein photoschaltbarer Ligand zur Regulierung der Rezeptoraktivierung

  2017cites this paper
• Structural basis of biased signaling in the angiotensin II type 1 receptor

  2017cites this paper
• A Photoswitchable Dualsteric Ligand Controlling Receptor Efficacy.

  2017cites this paper
• Engineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled Receptor

  2017cites this paper
• Title : Engineered context-sensitive agonism – tissue-selective drug signaling through a G protein-coupled receptor

  2016cites this paper
• Superagonism at G protein‐coupled receptors and beyond

  2016cites this paper
• Follicle-stimulating hormone potentiates the steroidogenic activity of chorionic gonadotropin and the anti-apoptotic activity of luteinizing hormone in human granulosa-lutein cells in vitro.

  2016cites this paper
• Consciousness fluctuation during general anesthesia: a theoretical approach to anesthesia awareness and memory modulation

  2016cites this paper
• Molecular pharmacology of G protein‐coupled receptors

  2016cites this paper
• Label-free versus conventional cellular assays: Functional investigations on the human histamine H1 receptor.

  2016cites this paper